ReElement successfully processes 28% tungsten concentrate from international mining partners into 99.9% purity material, ...
Since the annual general meeting of AS Pro Kapital Grupp (registration code 10278802, hereinafter referred to as the Company) scheduled for 26 May 2026 did not have a quorum, the Management Board of ...
Farmers & Merchants Bank of Long Beach (OTCQX: FMBL) today announced that its board of directors has approved the Bank’s regular quarterly cash dividend of $28 per share on the Bank’s common and ...
A full truckload of Champion inventory, strong early sales, and limited-time LA County Fair pricing make the final days of the event a must-visit for Southern California shoppers. PROVO, UT / ACCESS ...
All figures are in US dollars unless otherwise stated. LEWISVILLE, Ark., May 26, 2026 (GLOBE NEWSWIRE) -- Smackover Lithium, a partnership between Standard Lithium Ltd. (“Standard Lithium” or the ...
VANCOUVER, BC / ACCESS Newswire / May 26, 2026 /Klondike Gold Corp. (TSXV:KG)(FRA:LBDP)(OTCQB:KDKGF) ("Klondike Gold" or the "Company") is pleased to announce that its 2026 diamond drilling program ...
Cosa Resources Corp. (TSXV: COSA) (OTCQB: COSAF) (FSE: SSKU) ("Cosa" or the "Company") is pleased to report that chemical assays confirm previously-announced radioactive intersections include up to 1.
Most people are still focused on the performance of large-cap, growth, and tech stocks. They're missing that small caps ...
Today, SBI announced that Bow River Capital, a Denver-based private alternative asset manager, has completed a strategic investment in the firm. The transaction marks the beginning of a new growth ...
Marvion Inc. (OTCQB: MVNC) today announced its financial results for the quarter ended March 31, 2026, highlighting continued revenue growth, improved profitability and strengthening operating cash ...
GFM Resources Limited (TSXV: GFM.H) (the "Company") is pleased to announce that it has granted, effective May 25, 2026, incentive stock options to certain directors, officers and consultants of the ...
Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results